We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In three of the cases, it recommended less addictive alternatives be given; it suggested one to 15 pills after 11 of the procedures and no more than 16 to 20 tabs after six of them. Read More
A Johns Hopkins University panel has released guidelines for prescribing opioids after 20 common surgical procedures, noting that post-op overprescribing been a major driver of the nation’s addiction crisis. Read More
Two Democratic senators slammed HHS Secretary Alex Azar for blaming pharmacy benefit managers and drug distributors — and letting manufacturers off the hook — for high drug prices. Read More
Drug manufacturers set higher prices even when rebates for pharmacy benefit managers decrease, contradicting allegations that rebates may help drive the increases, according to a new report released by the Pharmaceutical Care Management Association (PCMA). Read More
“According to the National Prescription Audit, we have already made significant progress in reducing prescription rates over the past year,” said Attorney General Jeff Sessions. Read More
The company claimed the agency’s handling of bulk compounding laws violates the 2013 Drug Quality and Security Act, treating the laws as non-binding guidance rather than a legal mandate. Read More
PhRMA praised certain recommendations in a new report from the National Governors Association that lays out strategies governors are considering to lower drug prices, but questioned its suggestions on value-based pricing, a cap on Medicaid spending and more price transparency. Read More
The Justice Department and the Drug Enforcement Administration are proposing a major cut in production of the most commonly abused opioids in 2019. Read More